Tempest Therapeutics, Inc. Accrued Liabilities, Current
Tempest Therapeutics, Inc. (TPST) had Accrued Liabilities, Current of $715.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-08-13
- 2026-06-30: Accrued Liabilities, Current $715.00K.
- 2026-03-31: Accrued Liabilities, Current $1.16M.
- 2025-12-31: Accrued Liabilities, Current $937.00K.
- 2025-09-30: Accrued Liabilities, Current $1.35M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $715.00K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $1.16M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $937.00K 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $1.35M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $1.22M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $4.99M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $2.73M 10-K · filed 2026-03-30 | |
| 2024-09-30 | $1.46M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $2.38M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $1.52M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $1.67M 10-K · filed 2025-03-27 | |
| 2023-09-30 | $2.00M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $2.45M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $2.54M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $2.96M 10-K · filed 2024-03-19 | |
| 2022-09-30 | $2.58M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $2.19M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $3.23M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $1.59M 10-K · filed 2023-03-22 | |
| 2021-09-30 | $1.66M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $948.00K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $1.59M 10-Q · filed 2022-05-13 | $2.81M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $665.00K 10-K · filed 2022-03-29 | $5.53M 10-K · filed 2021-03-29 |
| 2020-09-30 | $665.00K 10-Q · filed 2021-11-10 | $4.27M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $7.37M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $6.74M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $9.07M 10-K · filed 2021-03-29 | |
| 2019-09-30 | $5.78M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $6.15M 10-Q · filed 2019-08-12 | |
| 2019-03-31 | $5.75M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $7.63M 10-K · filed 2020-03-11 | |
| 2018-09-30 | $3.28M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $3.99M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $4.01M 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $2.62M 10-K · filed 2019-04-01 | $5.56M 10-K · filed 2018-03-15 |
| 2017-09-30 | $6.21M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $9.00K 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $8.00K 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $11.03M 10-K · filed 2018-03-15 | |
| 2015-12-31 | $7.89M 10-K · filed 2017-03-02 | |
| 2014-12-31 | $7.65M 10-K · filed 2016-02-26 | |
| 2014-09-30 | $5.82M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $5.65M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $4.34M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $4.12M 10-K · filed 2015-03-16 | |
| 2013-09-30 | $1.36M 10-Q · filed 2013-11-13 | |
| 2013-06-30 | $1.60M 10-Q · filed 2013-08-13 | |
| 2013-03-31 | $1.15M 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $1.21M 10-K · filed 2014-02-27 | |
| 2012-09-30 | $845.00K 10-Q · filed 2012-11-13 | |
| 2012-06-30 | $1.21M 10-Q · filed 2012-08-14 | |
| 2011-12-31 | $399.00K 10-K · filed 2013-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |